Aaron D. Martin

Statistics

Publications

Citations

122

H-Index

Active since

2020

Affiliations

Integrated BioTherapeutics (United States)(Current)

Aaron D. Martin is an author at Integrated BioTherapeutics (United States) specializing in immunology, t cell receptors, and tumor-associated antigens.

ORCID

Publications per year

2020–2022

Publications

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo

Mark L. Sandberg, Xueyin Wang, Aaron D. Martin et al. · Science Translational Medicine · 2022 · 53 citations

Medicine, Immunology, Oncology +17

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

Xueyin Wang, Mark L. Sandberg, Aaron D. Martin et al. · Journal of Immunotherapy · 2021 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen

Xu Han, Agnes E. Hamburger, Jee‐Young Mock et al. · Molecular Immunology · 2020 · 18 citations

Life Sciences, Immunology, Molecular Biology +16

HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease

Aaron D. Martin, Mark Daris, James A. Johnston et al. · Cytotherapy · 2020 · 16 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity

Talar Tokatlian, Grace E. Asuelime, Martin S. Naradikian et al. · Cancer Research Communications · 2022 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 5